← FDA DRUG APPROVALS

FDA ANDA · ANDA076663

CARBIDOPA AND LEVODOPA

Sponsor: KV PHARM

APPLICATION
ANDA076663
TYPE
ANDA
ORIGINAL APPROVAL
2004-06-24
LATEST ACTION
2004-06-24
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

CARBIDOPA AND LEVODOPADiscontinued
CARBIDOPA 50MG, LEVODOPA 200MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2004-06-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →